EGF treatment of endometrial carcinoma cells was reported to induce an EGFR-dependent RIP of EpCAM, resulting in complete EpEX shedding from the membrane and in release of EpICD, which serves as a nuclear transcriptional inducer of an EMT program [36]. Here, EGFR is linked to endometrial carcinoma.